Literature DB >> 21824852

Telepresence index for bilateral teleoperations.

Pyung Hun Chang1, Jonghyun Kim.   

Abstract

This paper proposes a performance index called telepresence index for bilateral teleoperation, which can be used both for the performance evaluation of bilateral control architectures and for design purposes. This index is intended to represent a comprehensive performance objective consisting of transparency and kinematic correspondence, which are two major performance objectives of bilateral teleoperation. In order to quantify the performance objective, telepresence index has employed the error vector magnitude, which enables a seamless combination of magnitude and phase errors and the accommodation of time delay. In comparison with existing performance indices, it was observed that telepresence index possesses the comprehensiveness of performance objectives, magnitude/phase integrity, and the capacity to include time delay, which the others lack in one way or another. The index was applied to evaluate the performances of two widely known control architectures: PD-type bilateral control and Ueda's ideal control. In all cases, telepresence index has been compared favorably with the other indices in terms of clarity, convenience, and accuracy, thereby demonstrating its superiority.

Mesh:

Year:  2011        PMID: 21824852     DOI: 10.1109/TSMCB.2011.2160849

Source DB:  PubMed          Journal:  IEEE Trans Syst Man Cybern B Cybern        ISSN: 1083-4419


  2 in total

1.  Two-Channel Transparency-Optimized Control Architectures in Bilateral Teleoperation With Time Delay.

Authors:  Jonghyun Kim; Pyung Hun Chang; Hyung-Soon Park
Journal:  IEEE Trans Control Syst Technol       Date:  2013-01       Impact factor: 5.485

2.  Remote Assessment of Post-Stroke Elbow Function Using Internet-Based Telerobotics: A Proof-of-Concept Study.

Authors:  Jonghyun Kim; Minki Sin; Won-Seok Kim; Yu-Sun Min; Woojin Kim; Daegeun Park; Nam-Jong Paik; Kyujin Cho; Hyung-Soon Park
Journal:  Front Neurol       Date:  2020-12-03       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.